InvestorsHub Logo

Lemoncat

09/15/20 4:24 PM

#323731 RE: thefamilyman #323694

Well that's ok. You're allowed to prefer whichever situation you like.

I was noting that, with regard to efficacy, we are not beyond hamsters and mice. AB8 now is.

Until we either have efficacy data in vivo or in clincial trials, we have not advanced to the point AB8 has with regard to efficacy.

Go IPIX!